|
Zebrafish Models of Cancer
|
ZIA BC 010549
|
$902,101
|
$180,420
|
Hickstein, Dennis
|
CCR (NCI)
|
|
YALE COMPREHENSIVE CANCER CENTER
|
5P30CA016359-31
|
$1,889,710
|
$132,280
|
Lynch, Thomas
|
YALE UNIVERSITY
|
|
Wnt Antagonist Gene Hypermethylation in Circulating DNA: Cancer Biomarker
|
ZIA BC 011050
|
$55,899
|
$5,590
|
Rubin, Jeffrey
|
CCR (NCI)
|
|
Vitamin D Pooling Project
|
ZIA CP010195-10436
|
$398,953
|
$63,833
|
Albanes
|
DCEG (NCI)
|
|
Vitamin D and Ovarian Cancer Prevention and Treatment
|
5R01CA111334-05
|
$244,382
|
$244,382
|
BAI, WENLONG
|
UNIVERSITY OF SOUTH FLORIDA
|
|
Visualization and Analysis of the TCGA Data Using the UCSC Cancer Genomics Browse
|
5R21CA135937-02
|
$180,460
|
$59,552
|
HAUSSLER, DAVID
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-26
|
$430,954
|
$17,238
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
VCU Minority-Based CCOP
|
3U10CA052784-19S1
|
$99,999
|
$4,000
|
roberts, john
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-19
|
$314,164
|
$12,567
|
Roberts, John
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Vascular Leukocytes influence the tumor microenvironment
|
5R01CA124515-03
|
$303,810
|
$303,810
|
Conejo-Garcia, Jose
|
DARTMOUTH COLLEGE
|
|
Vascular Leukocytes Induce regulatory T cells (Treg) in Tumors
|
5R01CA116779-04
|
$271,456
|
$135,728
|
COUKOS, GEORGE
|
UNIVERSITY OF PENNSYLVANIA
|
|
VALIDATING AND TARGETING LYSOPHOSPHATIDIC ACID ACYLTRANSFERASE-BETA IN CANCER
|
1R01CA131400-01A2
|
$346,525
|
$346,525
|
Springett, Gregory
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$283,437
|
$28,344
|
Hodge, James
|
CCR (NCI)
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$330,677
|
$33,068
|
Hodge, James
|
CCR (NCI)
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S1
|
$74,165
|
$3,708
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
3P30CA014089-34S2
|
$100,000
|
$5,000
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-34
|
$6,658,653
|
$332,933
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
5U10CA035119-25
|
$1,884,250
|
$75,370
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
|
5P01CA017054-31
|
$1,500,330
|
$495,109
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S2
|
$1,678,886
|
$67,155
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S3
|
$80,987
|
$3,239
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-24S4
|
$99,840
|
$3,994
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-09S1
|
$57,442
|
$57,442
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
3P50CA083639-10S1
|
$141,526
|
$141,526
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of Texas MD Anderson SPORE in Ovarian Cancer
|
5P50CA083639-10
|
$2,001,032
|
$2,001,032
|
BAST, ROBERT
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
University of New Mexico Cancer Center Support
|
3P30CA118100-05S2
|
$60,764
|
$3,038
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
University of New Mexico Cancer Center Support
|
5P30CA118100-05
|
$1,371,380
|
$68,569
|
WILLMAN, CHERYL
|
UNIVERSITY OF NEW MEXICO
|
|
Tumor-Associated Antigens in Early Stage Serous Carcinoma
|
5R01CA122581-04
|
$258,389
|
$258,389
|
Roden, Richard
|
JOHNS HOPKINS UNIVERSITY
|
|
Tumor Suppressor Protein, p53
|
ZIA BC 005599
|
$309,113
|
$154,557
|
Appella, Ettore
|
CCR (NCI)
|
|
Tumor Host Range Mutants of Polyoma and Their Targets
|
5R01CA092520-09
|
$634,992
|
$634,992
|
BENJAMIN, THOMAS
|
HARVARD UNIVERSITY (MEDICAL SCHOOL)
|
|
Tumor -Targeting Chemotherapeutic Agents
|
2R01CA103314-18A1
|
$322,229
|
$80,557
|
OJIMA, IWAO
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Treatment of Chemotherapy-Resistant Human Ovarian Cancer by Administration of CPE
|
5R01CA122728-02
|
$346,357
|
$346,357
|
SANTIN, ALESSANDRO
|
YALE UNIVERSITY
|
|
Translational Surgical Pathology
|
ZIE SC 000853
|
$287,498
|
$28,750
|
Merino, Maria
|
CCR (NCI)
|
|
Translational Research in Cancer
|
3P30CA056036-10S1
|
$63,390
|
$1,902
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
3P30CA056036-10S2
|
$98,650
|
$2,960
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Research in Cancer
|
5P30CA056036-10
|
$3,102,433
|
$93,073
|
PESTELL, RICHARD
|
THOMAS JEFFERSON UNIVERSITY
|
|
Translational Applications of mda-7/IL-24 in Cancer
|
5P01CA104177-05
|
$1,353,467
|
$460,179
|
FISHER, PAUL
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Transforming growth factor beta signaling pathways
|
5R01CA055536-18
|
$308,158
|
$77,040
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
Trans-NIH Angiogenesis Core Facility
|
ZIC BC 010964
|
$882,625
|
$176,525
|
Cuttitta, Frank
|
CCR (NCI)
|
|
Training of Academic Gynecologic Oncologists
|
5T32CA101642-05
|
$377,721
|
$124,648
|
GERSHENSON, DAVID
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
TRAIL-induced Cell Death in Breast Cancer Cells
|
ZIA SC 007263
|
$315,802
|
$31,580
|
Lipkowitz, Stanley
|
CCR (NCI)
|
|
TRAIL Receptor Signaling in Human Tumors
|
5R01CA124545-02
|
$419,924
|
$209,962
|
THORBURN, ANDREW
|
UNIVERSITY OF COLORADO DENVER
|
|
Total Synthesis of Anticancer Agents Superstolides A & B
|
5R01CA109208-03
|
$257,514
|
$64,379
|
JIN, ZHENDONG
|
UNIVERSITY OF IOWA
|
|
Topoisomerase I Inhibitors in Leukemia and Solid Tumors
|
5R01CA073709-11
|
$221,813
|
$55,453
|
KAUFMANN, SCOTT
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
|
Tools for Large-Scale Analysis of Driver Pathways
|
5R21CA135877-02
|
$184,500
|
$60,885
|
KARCHIN, RACHEL
|
JOHNS HOPKINS UNIVERSITY
|
|
Tissue Array Research Program
|
ZIC BC 010923
|
$787,346
|
$39,367
|
Hewitt, Stephen
|
CCR (NCI)
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
3R01CA115483-05S2
|
$60,652
|
$60,652
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
Therapeutic Targeting Agents for Ovarian Cancer
|
5R01CA115483-05
|
$299,843
|
$299,843
|
LAM, KIT
|
UNIVERSITY OF CALIFORNIA DAVIS
|
|
The Use of Transcriptional Factors as Targets and Agents in Carcinogenesis
|
ZIA SC 000165
|
$137,617
|
$34,404
|
Birrer, Michael
|
CCR (NCI)
|
|
The use of chitosan for cancer vaccine delivery
|
ZIA BC 010969
|
$421,673
|
$84,335
|
Greiner, Jack
|
CCR (NCI)
|
Total relevant funding to Ovarian Cancer for this search: $110,121,501
|